Turn Therapeutics
TTRX | NASDAQ
$8.55
-$0.79 (-8.51%)
At close: Nov 16, 2026, 4:00 PM ET
$8.48
-$0.07 (-0.82%)
After-hours:
Nov 16, 2026, 4:43 PM ET
Turn Therapeutics Company Profile
Company profile explainedCompany Profile
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
Key Executives
| Name | Position |
|---|---|
| Bradley E. Burnam | Founder, Chief Executive Officer & Director |
| Zuraiz Chaudhary | Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer |
| Mohammed Zubair | Controller |
| Neilesh Shailesh Ghodadra | Chief Medical Officer & Director |
| Robert R. Redfield | Chief Scientific Officer |
| Stephen Hahn FASTRO | Executive Clinical & Regulatory Lead |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 19, 2026 | ARS | Filing |
| Oct 19, 2026 | DEF 14A | Filing |
| Oct 07, 2026 | 8-K | Current Report |
| Sep 10, 2026 | 8-K | Current Report |
| Sep 09, 2026 | 8-K | Current Report |
| Aug 26, 2026 | D | Filing |
| Aug 18, 2026 | 8-K | Current Report |
| Aug 17, 2026 | 8-K | Current Report |
| Aug 12, 2026 | 10-Q | Quarterly Report |
| Aug 12, 2026 | 8-K | Current Report |
Turn Therapeutics
| Country | United States |
| IPO Date | Oct 8, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Bradley E. Burnam |
Contact Details
250 N Westlake Blvd Westlake Village,
California 91362 United States
Stock Details
| Ticker Symbol | TTRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002023016 |
| CUSIP Number | 90021W105 |
| ISIN Number | US90021W1053 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove TTRX